Singapore Exchange stock today: SGX shares end higher as 2026 listings and GDP data set the tone
4 January 2026
2 mins read

Singapore Exchange stock today: SGX shares end higher as 2026 listings and GDP data set the tone

NEW YORK, January 4, 2026, 09:11 ET — Market closed.

  • Singapore Exchange Ltd (SGX:S68) last closed up 0.53% at S$17.05 on Jan. 2, with the stock down 1.22% over the past week. 1
  • Two deals in the pipeline — including co-living operator The Assembly Place and a possible secondary listing by Hong Kong-listed Concord New Energy — have put IPO momentum back in focus.
  • Singapore’s economy expanded 4.8% in 2025, with fourth-quarter growth at 5.7%, official advance estimates showed.

Singapore Exchange Ltd shares ended the last session higher as investors weighed early signs of a pick-up in listing activity and a firmer macro backdrop for Singapore equities.

The U.S. market is closed on Sunday, and SGX shares last traded on Friday in Singapore, when the exchange operator finished at S$17.05.

Why this matters now is straightforward. SGX’s earnings are closely tied to market activity — new listings, secondary fund-raisings and trading volumes — so the first read on the year’s pipeline can shape sentiment quickly.

After several years in which Singapore’s equity market struggled to attract a steady flow of initial public offerings (IPOs), investors are watching whether 2026 starts with more deals that can lift liquidity and fee income.

The immediate catalyst has been a rebound in “pipeline talk”. The Assembly Place is seeking an SGX Catalist IPO, while renewable energy player Concord New Energy is exploring a secondary listing — meaning a company already listed elsewhere also trades in Singapore — the report said. A clearer calendar matters for SGX because new listings often drive follow-on trading and research coverage.

Catalist is SGX’s sponsor-supervised board for growth companies, where issuers must be backed by an approved sponsor that guides the listing process and ongoing compliance.

Macro has also been supportive. OCBC economist Selena Ling called 2025 a “stunning year” for Singapore after preliminary data showed the fastest annual growth since 2021, helped by strong manufacturing tied to AI-related demand, Reuters reported. 2

Policy efforts remain a second pillar for the stock. Singapore’s central bank has said it aims to make SGX-Nasdaq dual listings easier via a “listing bridge” expected to go live around mid-2026, part of a broader push to deepen the local equities market. 3

For SGX investors, the question is whether more listings translate into sustained trading, not just debut-day headlines. Listing fees can be lumpy; trading and data-related revenue tends to be more sensitive to day-to-day market confidence and volatility.

Analyst views remain cautious at current levels. MarketScreener data show a mean “HOLD” consensus from 15 analysts, with an average target price of S$16.84 — below the last close of S$17.05. 4

Before the next session, traders will likely keep an eye on whether the stock can hold above the recent low near S$16.96 or push past the last session high of S$17.14, levels that often act as short-term support and resistance.

Investors will also look for clarity on SGX’s next results and the tone around securities and derivatives activity into the new year. MarketScreener’s company calendar lists Jan. 28 as the projected date for SGX’s next earnings release. 5

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
ASX Ltd stock today: shares cling to the low end of the 52-week range as 2026 opens quietly
Previous Story

ASX Ltd stock today: shares cling to the low end of the 52-week range as 2026 opens quietly

BSE share price today: Bombay Stock Exchange operator ends higher after SEBI-governance hiring move
Next Story

BSE share price today: Bombay Stock Exchange operator ends higher after SEBI-governance hiring move

Go toTop